Clinical Trial Update: Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports completion of a Phase 1/Phase 2 safety study of Dimebon (latrepirdine) for Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Dimebon (latrepirdine)

Snippet

Sponsor: Medivation, Inc. | Conditions: Huntington's Disease | Phase 1, Phase 2 | Status: COMPLETED